NeurologyLive Friday 5 — May 29, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: CMSC 2020 Day 1: Peter Calabresi, MD, on CNS Immune Responses in Progressive MS
Peter Calabresi, MD, delivers the Whitaker Lecture as part of the 2020 CMSC Virtual Annual Meeting.
2: CMSC 2020 Day 2: Brenda Banwell, MD, on Current Perspectives of Pediatric MS Care and Research
Brenda Banwell, MD, presents her lecture titled, "Current Perspectives of Pediatric MS Care and Research" as part of the 2020 CMSC Virtual Annual Meeting.
3: Shadi Yaghi, MD: Incidence of Stroke in Patients With COVID-19
The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone gives perspective on his recent study of patients with stroke and COVID-19 and the difficulties in understanding their relationship.
4: Ocrelizumab Has Similar Effects in MS With Shorter Infusion Time
The Genentech agent, which is approved for patients with relapsing-remitting multiple sclerosis, showed no new safety signals in a comparison between conventional and shorter infusion times.
5: Reviewing a Case of Parkinson Disease OFF Episodes
Peter A. LeWitt, MD, offers expert perspective on the identification and management of OFF episodes in a 68-year-old man with Parkinson disease.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
